filmov
tv
Moderna announces 'positive' early results in coronavirus vaccine trial
Показать описание
The vaccine candidate "has the potential to prevent COVID-19 disease," said Dr. Tal Zaks.
WCVB Channel 5 Boston
tal zaks
biotechnology company
vaccine candidate
COVID-19
coronavirus
Рекомендации по теме
0:01:07
Moderna announces 'positive' early results in coronavirus vaccine trial
0:03:24
Moderna Announces Positive Interim Results For COVID-19 Vaccine
0:02:54
Moderna announces positive Phase 1 trial data for coronavirus vaccine
0:00:48
Moderna Announces ‘Encouraging’ Coronavirus Vaccine Trial Results
0:04:42
Moderna announces positive results for Omicron vaccine | ANC
0:03:24
Moderna COVID-19 vaccine shows positive early results
0:03:17
Moderna reports positive early vaccine trial results
0:03:04
Moderna reports positive data on early-stage coronavirus vaccine trial, shares surge
0:01:05
Connect the Dots: Moderna vaccine shows positive early results
0:03:20
Ask Dr. Nandi: Moderna’s coronavirus vaccine shows encouraging early results in human safety trial
0:09:46
Coronavirus Update: After Promising Results In COVID 19 Vaccine, Moderna Inc Shares Soars
0:35:55
Oxford Vaccine. Moderna Vaccines Shows Good Results
0:08:04
Promising early results from coronavirus vaccine trial
0:01:08
Moderna’s Coronavirus Vaccine Shows Signs of Early Progress
0:02:14
Expert's view on Moderna vaccine trial results
0:07:06
Moderna early trial results raise COVID-19 vaccine hopes
0:10:03
Coronavirus: Moderna CEO on the promising preliminary results of early-stage study
0:00:37
Moderna: Early coronavirus vaccine results are encouraging
0:01:16
Coronavirus: Moderna reports early signs of progress during phase 1 of vaccine trial
0:00:40
Moderna Coronavirus Vaccine Shows Promising Results In Phase 1
0:02:49
MODERNA Vaccine Shows Promise in Early Results
0:13:00
Moderna CEO talks positive results from phase one of coronavirus vaccine trial
0:06:40
Will be a long road ahead for Moderna: Former FDA commissioner
0:09:55
Yale professor breaks down Moderna's timeline for a COVID-19 vaccine